These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 441257)

  • 1. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination.
    Harrison JD; David AJ
    Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257
    [No Abstract]   [Full Text] [Related]  

  • 2. Dependency of chelation efficacy upon time after first DTPA injection.
    Lloyd RD; Taylor GN; Mays CW; Jones CW; Bruenger FW; Atherton DR
    Radiat Res; 1979 Jun; 78(3):448-54. PubMed ID: 451166
    [No Abstract]   [Full Text] [Related]  

  • 3. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 4. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium.
    Stather JW; Rodwell P
    Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Distribution and excretion of plutonium-239 from the body of rats under exposure to penthacine and macro quantities of iron with penthacine].
    Rushonik SI; Shvydko NS; Popov DK; Vorozhtsova LN
    Radiobiologiia; 1978; 18(5):719-23. PubMed ID: 715193
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental background for prompt treatment with DTPA of 239Pu-contaminated wounds.
    Volf V
    Health Phys; 1974 Sep; 27(3):273-7. PubMed ID: 4436049
    [No Abstract]   [Full Text] [Related]  

  • 8. Plutonium-contaminated wound studies. BNWL-714.
    McClanahan BJ
    BNWL Rep; 1968 May; ():6.3-6+. PubMed ID: 5307100
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
    Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
    Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
    [No Abstract]   [Full Text] [Related]  

  • 10. [Report on a plutonium-239 contaminated lacerated and incised wound].
    Ohlenschläger L; Schieferdecker H
    Strahlentherapie; 1973 Dec; 146(6):675-84. PubMed ID: 4792264
    [No Abstract]   [Full Text] [Related]  

  • 11. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy.
    Hall RM; Poda GA; Fleming RR; Smith JA
    Health Phys; 1978 May; 34(5):419-31. PubMed ID: 711453
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
    Stradling GN; Gray SA; Moody JC; Hodgson A; Raymond KN; Durbin PW; Rodgers SJ; White DL; Turowski PN
    Int J Radiat Biol; 1991 May; 59(5):1269-77. PubMed ID: 1675243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of DTPA on the metabolism of inhaled 239PuF4 in beagles.
    McDonald KE; Dilley JV; Sanders CL; Mahaffey JA
    Health Phys; 1979 May; 36(5):632-5. PubMed ID: 489316
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat after simulated wound contamination as nitrates.
    Stradling GN; Gray SA; Moody JC; Pearce MJ; Wilson I; Burgada R; Bailly T; Leroux Y; Raymond KN; Durbin PW
    Int J Radiat Biol; 1993 Jul; 64(1):133-40. PubMed ID: 8102166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resorption coefficients and prevention of Pu-239 oxide entry through microtrauma of the skin].
    Bazhin AG
    Gig Sanit; 1995; (3):32-5. PubMed ID: 7635340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.